Home › Studies › PRJNA1121964
PRJNA1121964 SRP512954

Fecal metagenomes of IBS-D patients on S. boulardii, Wuhan

fecal metagenomes of irritable bowel syndrome patients

103 fecal samples from IBS-D patients in Wuhan, China, studying the effect of the probiotic Saccharomyces boulardii on gut microbiota in an intervention design. machine-written summary

103 samples · 103 runs · CN · Age unknown · 2024 · 13.36 Gbp / sample

Sources
✓Sequence archive 824–Abstract / description–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive824 sample values (collection date, country, health condition, health condition detail, latitude, location locality, location region, longitude)
– Abstract / descriptionno abstract or project description
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Probiotic (live microorganisms; single strain or mixture) design single_arm_before_after · population ibs · Saccharomyces boulardii probiotic treatment in IBS-D patients

“IBS-D patients receiving S. boulardii treatment” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
unknown103
Condition
ibs103
Country
CN103
Body site
primary103
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 103 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 13.36 Gbp per sample0130Gbp
Community composition
Faecalibacterium 17.7%Phocaeicola 9.0%Roseburia 8.8%Bacteroides 6.2%Enterocloster 5.0%Blautia_A 4.2%Lachnospira 3.2%Mediterraneibacter 2.5%Escherichia 2.3%Ruminococcoides 2.1%Gemmiger 1.8%Megamonas 1.6%not assigned to a genus 3.3%other genera 32.4%

Genera, mean relative abundance over 92 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country103 100%103
health_condition103 100%103
subject_id0 0%
collection_date103 100%103
detailed_location103 100%
health_condition_detail103 100%103
latitude103 100%103
location_locality103 100%103
location_region103 100%103
longitude103 100%103
Details
Archive description

A growing body of evidence implicates the gut microbiome as a critical factor in irritable bowel syndrome (IBS) pathophysiology, prompting the exploration of probiotics, such as Saccharomyces boulardii (S. boulardii), for IBS treatment. However, the effects of S. boulardii on the gut microbiota of IBS patients are still not fully understood. Therefore, fecal metagenomes were analyzed for IBS-D patients receiving S. boulardii treatment.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.78. Assay shotgun_dna.

  • host study.title · “irritable bowel syndrome patients”
  • body site study.title · “fecal metagenomes”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN41770116collection_date2020R10.90biosample.attribute:collection_date2020
SAMN41770116countryCNR10.90sample.attr.geo_loc_nameChina: Wuhan
SAMN41770116health_conditionibsR10.85biosample.attribute:titleMetagenome or environmental sample from human gut metagenome
SAMN41770116health_condition_detailMetagenome or environmental sample from human gut metagenomeR10.85biosample.attribute:titleMetagenome or environmental sample from human gut metagenome
SAMN41770116latitude30.1100R10.90biosample.attribute:lat_lon30.11 N 114.23 E
SAMN41770116location_localityWuhanR10.85biosample.attribute:geo_loc_nameChina: Wuhan
SAMN41770116location_regionHubeiR10.60biosample.attribute:lat_lon30.11 N 114.23 E
SAMN41770116longitude114.2300R10.90biosample.attribute:lat_lon30.11 N 114.23 E
Sequencing

103 runs over 103 samples · mean 13.46 Gbp per run (median 13.36 Gbp, total 1,386.65 Gbp; 103 runs with a base count) · layout PAIRED 103 · platform ILLUMINA 103 · models Illumina NovaSeq 6000 (103) · 89% of runs with a Sandpiper profile · first public 2024-12-29

Authors (0)

No author record.

Help complete this project

2 of the 4 core fields are below 50% coverage: age_category, subject_id. Share metadata

Downloads

PRJNA1121964.csv.gz (3.3 KB) · parquet (74.0 KB) — all 103 samples, every field with route and confidence · PRJNA1121964_determinations.csv.gz (5.4 KB) — 824 evidence rows

Samples (103 · every field this project has values for · hover a cell for its source)
Loading the sample table…